Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Plauschinat

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 29, 2008
Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapyMichael Dickson, Craig A Plauschinat
Ethnicity & Disease|May 30, 2008
Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatmentMichael Dickson, Craig A Plauschinat
The American Journal of Managed Care|August 10, 2007
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimenAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Epilepsy & Behavior : E&B|July 28, 2020
Real-world hospitalization risk in patients with epilepsy treated with perampanelXuan Li, Feride Frech, Craig A Plauschinat, et al.
Clinical Therapeutics|May 1, 2012
Failure to intensify hypertension therapy after rejected aliskiren claimsFeng Zeng, Jinhee Park, Craig A Plauschinat, et al.
Congestive Heart Failure (Greenwich, Conn.)|July 25, 2009
Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failureGregory Hess, Ronald Preblick, Jerrold Hill, et al.
Pharmacotherapy|July 28, 2007
Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapyAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Journal of the American Board of Family Medicine : JABFM|January 6, 2007
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapiesWilliam J Elliott, Craig A Plauschinat, Grant H Skrepnek, et al.
Journal of the American Geriatrics Society|January 9, 2008
Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004Dong-Churl Suh, Chul-Min Kim, In-Sun Choi, et al.
Drugs & Aging|June 28, 2008
Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysisCarl V Asche, Carrie McAdam-Marx, Laura Shane-McWhorter, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 29, 2008
Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapyMichael Dickson, Craig A Plauschinat
Ethnicity & Disease|May 30, 2008
Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatmentMichael Dickson, Craig A Plauschinat
The American Journal of Managed Care|August 10, 2007
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimenAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Epilepsy & Behavior : E&B|July 28, 2020
Real-world hospitalization risk in patients with epilepsy treated with perampanelXuan Li, Feride Frech, Craig A Plauschinat, et al.
Clinical Therapeutics|May 1, 2012
Failure to intensify hypertension therapy after rejected aliskiren claimsFeng Zeng, Jinhee Park, Craig A Plauschinat, et al.
Congestive Heart Failure (Greenwich, Conn.)|July 25, 2009
Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failureGregory Hess, Ronald Preblick, Jerrold Hill, et al.
Pharmacotherapy|July 28, 2007
Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapyAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Journal of the American Board of Family Medicine : JABFM|January 6, 2007
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapiesWilliam J Elliott, Craig A Plauschinat, Grant H Skrepnek, et al.
Journal of the American Geriatrics Society|January 9, 2008
Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004Dong-Churl Suh, Chul-Min Kim, In-Sun Choi, et al.
Drugs & Aging|June 28, 2008
Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysisCarl V Asche, Carrie McAdam-Marx, Laura Shane-McWhorter, et al.
Pageof 2